BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7232850)

  • 1. A prospective screening program: current screening and its status.
    Goldin A; Venditti JM
    Recent Results Cancer Res; 1981; 76():176-91. PubMed ID: 7232850
    [No Abstract]   [Full Text] [Related]  

  • 2. Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute.
    Goldin A; Venditti JM; Macdonald JS; Muggia FM; Henney JE; Devita VT
    Eur J Cancer (1965); 1981 Feb; 17(2):129-42. PubMed ID: 6894902
    [No Abstract]   [Full Text] [Related]  

  • 3. The new NCI screen and its implications for clinical evaluation.
    Goldin A; Venditti JM
    Recent Results Cancer Res; 1980; 70():5-20. PubMed ID: 7355249
    [No Abstract]   [Full Text] [Related]  

  • 4. Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.
    Venditti JM; Wesley RA; Plowman J
    Adv Pharmacol Chemother; 1984; 20():1-20. PubMed ID: 6398966
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute.
    Goldin A; Venditti JM
    Cancer Treat Rev; 1980 Dec; 7(4):167-76. PubMed ID: 7214373
    [No Abstract]   [Full Text] [Related]  

  • 6. [Introduction of new screening system in National Cancer Institute].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
    [No Abstract]   [Full Text] [Related]  

  • 7. [New approaches in experimental cancerology: in search of therapeutic models].
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
    Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
    [No Abstract]   [Full Text] [Related]  

  • 8. The National Cancer Institute's Natural Products Antineoplastic Development Program.
    Douros J; Suffness M
    Recent Results Cancer Res; 1980; 70():21-44. PubMed ID: 7355247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary: screening for anti-cancer agents; the relative merits of in vitro and in vovo techniques.
    Connors TA; Phillips BJ
    Biochem Pharmacol; 1975 Dec; 24(24):2217-24. PubMed ID: 1218096
    [No Abstract]   [Full Text] [Related]  

  • 10. Host-tumor-drug interrelationships in the tumorous murine model.
    Goldin A
    Adv Enzyme Regul; 1980; 18():323-34. PubMed ID: 7446302
    [No Abstract]   [Full Text] [Related]  

  • 11. Some thoughts on experimental models and their clinical correlations.
    Carter SK
    Eur J Cancer (1965); 1973; 9(11-12):833-41. PubMed ID: 4804310
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening at the National Cancer Institute.
    Goldin A; Venditti JM; Carter SK
    Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
    [No Abstract]   [Full Text] [Related]  

  • 13. The evolution of cancer chemotherapy.
    Chabner BA
    Hosp Pract (Off Ed); 1985 Apr; 20(4):115-9, 123-7. PubMed ID: 3932415
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness and limitations of murine tumor models for the identification of new antitumor agents.
    Goldin A; Johnson RK; Venditti JM
    Antibiot Chemother (1971); 1980; 28():1-7. PubMed ID: 6998358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental chemotherapy of human tumors heterotransplanted in nude mice.
    Giovanella BC
    Antibiot Chemother (1971); 1980; 28():21-7. PubMed ID: 6998362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of tumours in immuno-deprived mice.
    Davies AJ
    Recent Results Cancer Res; 1977; (62):13-6. PubMed ID: 601327
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A.
    Venditti JM; Johnson RK
    Recent Results Cancer Res; 1978; 63():49-57. PubMed ID: 705014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical toxicology protocols of the Laboratory of Toxicology.
    Prieur DJ; Young DM; Davis RD; Cooney DA; Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):159-77. PubMed ID: 412104
    [No Abstract]   [Full Text] [Related]  

  • 19. Human tumor testsystems: a new screening approach.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1986 Jun; (80):103-12. PubMed ID: 3753367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemosensitivity predictive tests: current status and future applications in chemotherapy of gastrointestinal cancers (author's transl)].
    Ballet F; Poupon R; Petit J; Darnis F
    Gastroenterol Clin Biol; 1982 Feb; 6(2):192-201. PubMed ID: 7060865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.